{"id":"W2087469963","doi":"10.1186/1471-2474-9-118","title":"A 6-week, multicentre, randomised, double-blind, double-dummy, active-controlled, clinical safety study of lumiracoxib and rofecoxib in osteoarthritis patients","year":2008,"lang":"en","type":"article","venue":"BMC Musculoskeletal Disorders","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Novartis Pharma","keywords":"Medicine; Tolerability; Rofecoxib; Adverse effect; Internal medicine; Diclofenac; Blood pressure; Peripheral edema; Anesthesia; Incidence (geometry); Cyclooxygenase","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005411402,0.001543095,0.004104191,0.0006902204,0.0007619326,0.0007483374,0.0008870896,0.002171197,0.00601158],"category_scores_gemma":[0.004695369,0.0008578859,0.00201009,0.0005299943,0.001411364,0.001139619,0.000537048,0.001932896,0.001129575],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006942645,"about_ca_system_score_gemma":0.001680031,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005278486,"about_ca_topic_score_gemma":0.0009204237,"domain_scores_codex":[0.9971943,0.001739818,0.0002893286,0.0003356184,0.0002103572,0.0002304451],"domain_scores_gemma":[0.9958951,0.001045271,0.001164519,0.0003635336,0.0004117431,0.001119826],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9597886,0.02197515,0.00146097,0.0005508047,0.0004691194,0.00004686387,0.0001061215,0.0001676526,0.004440718,0.00003673991,0.0002455812,0.01071174],"study_design_scores_gemma":[0.7039384,0.2895676,0.005330877,0.00002262269,0.0002309261,0.00003691858,0.00002208889,0.0001384508,0.0003433439,0.00002961686,0.000322941,0.00001613858],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9895437,0.00192886,0.0007431963,0.0001928396,0.0002037682,0.005886373,0.0004993796,0.00006563665,0.0009362472],"genre_scores_gemma":[0.9867942,0.001131793,0.002171197,0.0006973504,0.0005314003,0.00666842,0.0007114181,0.00001186245,0.001282292],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00601158,"threshold_uncertainty_score":0.02861857,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02672852170835261,"score_gpt":0.310400124914085,"score_spread":0.2836716032057324,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}